Good evening :)
Place Order
Add to Watchlist

Fredun Pharmaceuticals Ltd

FREDUN

Fredun Pharmaceuticals Ltd

FREDUN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹430 cr, stock is ranked 1,768
High RiskStock is 4.82x as volatile as Nifty
874.004.67% (-42.80)
874.004.67% (-42.80)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹430 cr, stock is ranked 1,768
High RiskStock is 4.82x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹430 cr, stock is ranked 1,768
High RiskStock is 4.82x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
29.814.470.07%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.586.020.60%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Fredun Pharmaceuticals Ltd. is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical formulations. The Company’s products include I V fluids, disposable syringes, infusion sets, surgical gloves and cottons etc.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 35.87%, vs industry avg of 8.45%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.03% to 0.09%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 43.93%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue25.8543.1858.6159.7197.40113.29135.29226.09276.50310.85
Raw Materialssubtract15.4431.2534.2042.9865.9686.12100.60176.45245.57270.85
Power & Fuel Costsubtract0.841.171.641.653.103.213.323.683.72
Employee Costsubtract3.223.834.925.198.048.958.6610.6611.53
Selling & Administrative Expensessubtract3.304.526.575.669.836.437.8012.7612.38
Operating & Other expensessubtract0.93-2.296.04-1.64-0.14-0.275.337.04-27.34
Depreciation/Amortizationsubtract0.550.801.141.291.331.882.002.162.813.55
Interest & Other Itemssubtract1.052.061.871.943.134.484.374.7410.3212.83
Taxes & Other Itemssubtract0.270.770.800.891.700.591.202.266.709.17
EPS1.054.465.976.0112.004.765.0415.0624.1231.88
DPS0.000.600.600.600.650.660.700.700.700.70
Payout ratio0.000.130.100.100.050.140.140.050.030.02

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual Report Unavailable

Investor Presentation

Jun 15PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Fredun Pharmaceuticals Ltd39.854.470.07%
Sun Pharmaceutical Industries Ltd43.576.220.75%
Cipla Ltd41.834.940.59%
Dr Reddy's Laboratories Ltd23.554.560.63%

Price Comparison

Compare FREDUN with any stock or ETF
Compare FREDUN with any stock or ETF
FREDUN
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding49.16%0.00%1.60%0.00%49.25%

Jun 2023

Aug 2023

Sep 2023

Dec 2023

Shareholding History

MarMayJunAugSepDec '230.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

FREDUN has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.74 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹0.70

Dividend/Share

0.70

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateSep 16, 2021

Final
Final | Div/Share: ₹0.70

Dividend/Share

0.70

Ex DateEx Date

Sep 16, 2021

Cash Dividend

Ex DateEx DateSep 16, 2019

Final
Final | Div/Share: ₹0.65

Dividend/Share

0.65

Ex DateEx Date

Sep 16, 2019

Cash Dividend

Ex DateEx DateSep 18, 2018

Final
Final | Div/Share: ₹0.60

Dividend/Share

0.60

Ex DateEx Date

Sep 18, 2018

Cash Dividend

Ex DateEx DateSep 20, 2017

Final
Final | Div/Share: ₹0.60

Dividend/Share

0.60

Ex DateEx Date

Sep 20, 2017